Dr. Ashish Srivastava is an Professor in the Department of Pharmaceutical chemistry, Pranveer Singh Institute of Technology, Pharmacy ,Kanpur. Graduate aptitude test of Engineering fellowship was awarded to him in 2006. He has 16 years of teaching experience and research experience in various fields. His field of research mainly includes the synthesis of antidiabetic, anti-inflammatory compounds, and bone targeting prodrugs. He has published a number of research papers in scientific journals. He has participated and delivered lectures at various National and International Symposia. He is also a member of several professional societies. Until now over ten students have completed their M.Pharm. degree under his guidance. He is the author of several stimulating books on organic and Medicinal chemistry.
EDUCATION
Ph.D. in Pharmaceutical Chemistry, 2013-2021, AKTU, Lucknow
M.Pharm. in Pharmaceutical Chemistry, 2006-2008, Meerut Institute of Engineering and Technology, Meerut
B.Pharm. with 70%, 2002-2006, Pharmacy College Azamgarh
B.Sc. with 63%, 2000-2002, CSJMU Kanpur
12th with 64%, 1999, B.N.S.D. Inter College Kanpur
10th with 60%, 1997, B.N.S.D. Inter College Kanpur
RESEARCH, TEACHING, or OTHER INTERESTS
Pharmacy, Pharmacology, Toxicology and Pharmaceutics, Drug Discovery, Organic Chemistry
61
Scopus Publications
303
Scholar Citations
9
Scholar h-index
8
Scholar i10-index
Scopus Publications
Modular Approach to In Silico Antiviral Multitargets Inhibitor: Molecular Dockings, Dynamics, Principal Component Analysis, Clustering, and Energy Landscape Suliman A. Almahmoud, Hamdoon A. Mohammed, Minhajul Arfeen, Mostafa M. Hegazy, Devendra K. Dhaked, Ashish Srivastava, Faizul Azam, Riaz A. Khan Chemistryselect, 2026 Antiviral multitarget inhibitory capacity of certain structural candidates against antiviral targets, M pro , PLpro, and RBD‐ACE2 interface were assessed in a modular approach. Among the structures analyzed, the compound tiliroside, present in Zygophyllum coccineum , emerged as the potent multitarget inhibitor in the molecular docking studies. Molecular dynamics simulations, performed for 100 ns in triplicate, confirmed the binding stability of the compound to M pro , PLpro, and RBD‐ACE2 interface, together with MM‐GBSA binding affinities of ∼ −93.55, −68.55, and −62.39 kcal/mol, respectively. The protein backbone RMSDs for these complexes remained within the range of ∼1.7 to 2.8 Å, indicating stable complexes. The root mean square fluctuation (RMSF) analysis, secondary structure monitoring, principal component analysis, clustering, and Gibbs free energy landscape assessments supported the stability of these complexes. Additionally, residue‐specific interaction analysis and binding energy decomposition provided insights into the key elements driving these bindings. The results underscored the potential of the tiliroside as a multitarget inhibitor of viral proteins.
Aryloxyethylamines Chalcones as Potential β3 AR Binders: Synthesis, In Vivo Antidiabetic and Molecular Modeling Studies Ashish Srivastava, Law Kumar, Parul Srivastava, Poonam Shukla, Minhajul Arfeen Chemistryselect, 2026 Diabetes mellitus is a progression involves worsening insulin resistance and β‐cell dysfunction, culminating in severe metabolic complications. In this work, chalcone‐based aryloxyethylamines were synthesized and evaluated for their antihyperglycemic activity using glucose tolerance test (GTT) and STZ‐induced DM rat models. Compounds 12 , 10 , 8 , 7 , 5, and 3 exhibited moderate to good anti‐DM activity ranging from 18.5% to 39.8% in GTT and 11.6% to 28.3% in STZ in vivo models. The most promising compounds 10 and 12 exhibited 31.1% and 39.8% glucose lowering in GTT and 28.3% and 22.9% in STZ‐induced DM rat model, respectively. Molecular docking for β3‐AR revealed strong binding affinity of the identified compounds to β3‐AR, with docking scores in the range of −7.8 to −8.9 kcal/mol and comparable to co‐crystallized ligand carazolol. Key interactions included hydrogen bonds with Asn312 and hydrophobic contacts with Val118, Val121, and Phe309. The most promising compound 10 and 12 displayed the binding score of −8.9 and −8.1 kcal/mol, respectively. The binding mode analysis showed that carbonyl oxygen of 10 and 12 displayed hydrogen bond with Asn312, in addition to hydrogen bond with Ser209 in 10 . Further, ring A of 10 and 12 occupied the aromatic hydrophobic core created by residues Phe308, Phe309, Val118, and Val121. The ethylamine side chain on ring B of 10 displayed hydrophobic interactions with Val205, Ala316, and Arg315, while ring B itself engages in a carbon hydrogen bond with Tyr204. The ethylamine side chain of 12 displayed carbon hydrogen bond with Asn332. Overall, the work resulted in the identification of 10 and 12 as potential β3‐AR binders.
A Comprehensive Review of the Phytochemicals, Nutritional Values, and Therapeutic Applications of Albizia lebbeck Aishwarya Bajpai, Pranay Wal, Ashish Srivastava, Anil K. Yadav, Ateet Srivastava Current Drug Therapy, 2026 Plants have been a source of medicinal phytoconstituents since ancient times and the knowledge has passed through generations of medicinal use. Medicinal plants contain not one but an amalgamation of various Phyto-derived moieties that are therapeutically active. One such plant that has come into light for its various employabilities is Albizia lebbeck, more commonly known as Siris. It is mainly grown in the Indian subcontinent and nearby countries such as Myanmar, Sri Lanka, and eastern Pakistan. Various studies investigating the dynamics of siris have reported therapeutic actions such as anti-inflammatory, anti-cancer, antioxidant, neuroprotective, anti-diarrheal activity, and anti-diabetic activity. These activities can be attributed to various Phytochemicals such as alkaloids, flavonoids, terpenes, and saponins. However, apart from these wellreported actions, multiple other therapeutic uses are currently under investigation such as antihyperlipidaemic. In this review, we presented its different types of therapeutic uses, its various Phyto constituents, and its botanical classification.
Liposomes as Transformative Tools in Drug Delivery, Therapeutics, and Beyond Ashish Srivastava, Anshuman Singh, Parul Srivastava, Ankita Wal, Pranay Wal, Anil K. Yadav, Awani K. Rai Current Drug Therapy, 2025 <p>Liposomes are spherical vesicles composed of lipid bilayers that have gained significant attention in the realm of drug delivery and therapeutic applications. They offer several advantages over traditional drug delivery systems, including: </p> <p> &#8226; Protection of drugs from degradation and clearance </p> <p> &#8226; Enhanced bioavailability </p> <p> &#8226; Reduced systemic toxicity </p> <p> &#8226; Precise, site-specific drug delivery </p> <p> To elucidate the multifaceted aspects of liposomes, from their fundamental structure and composition to their cutting-edge applications in medicine and biotechnology. </p> <p> This comprehensive review was conducted through a systematic search of relevant literature on liposomes. The search was limited to English-language articles published in the past 10 years. A total of 150 articles were selected for review based on their relevance and impact. </p> <p> The review provides a detailed overview of the following aspects of liposomes: </p> <p> &#8226; Structure and composition </p> <p> &#8226; Mechanism of action </p> <p> &#8226;Targeting strategies </p> <p> &#8226; Preparation methods </p> <p> <p> Biomedical and biotechnological applications </p> <p> Liposomes are a promising drug delivery platform with the potential to revolutionize the treatment of various diseases. Their unique properties, including biocompatibility, versatility, and tunability, render them ideal for encapsulating a wide range of therapeutic agents. The review highlights the significant progress made in liposome research in recent years, paving the way for their translation into clinical practice.</p>
Exploring Microspheres: Innovative Approaches in Drug Delivery and Medication Administration Parul Srivastava, Jasmeet Kaur, Ashish Srivastava, Ankita Wal, Pranay Wal, Anil Kumar Yadav, Awani K. Rai Current Drug Therapy, 2025 Introduction: This review explores the advancements in drug delivery systems using mi-crospheres, developed to overcome the limitations of traditional drug administration methods. Micro-spheres are engineered to deliver therapeutic agents to specific sites with controlled release, thereby improving treatment efficacy and reducing systemic side effects. Methodology: A comprehensive literature search was conducted using PubMed, Science Direct, Google Scholar, Bentham Science, Elsevier, Springer Nature, ResearchGate, Wikipedia, Frontiers, and Scribd. The search included English-language articles published between 2010 and 2025 using keywords such as “microspheres,” "drug delivery," "controlled release," "biodegradable polymers," "encapsulation," "targeted delivery," "vildagliptin microspheres," and "fenugreek extract delivery." A total of 119 articles were screened, and studies were selected based on their relevance to micro-sphere formulation techniques, polymer characteristics, drug release mechanisms, and their applica-tions. Result: Microspheres are being utilised as vehicles for transporting medicinal substances to particu-lar locations in controlled release systems. They are made up of synthetic polymers or proteins that degrade naturally. By combining the advantages of floating and high adhesiveness, microspheres can enhance the absorption into the bloodstream and regulate the release of medications, limiting dose regularity and improving conformity among patients. Using microspheres as a depot mechanism allows parenteral formulations to be administered under controlled conditions. Discussion: The utilisation of microspheres represents a significant advancement in drug delivery technology. Their ability to improve drug stability, bioavailability, and patient compliance has been well-documented. However, challenges such as manufacturing scalability and consistency remain key obstacles to widespread clinical adoption. Conclusion: Microspheres have sparked great curiosity about their ability to target various diseases. In the future, microspheres will be crucial for innovative medicine delivery by merging several meth-ods, particularly in the domains of genetic data and mutations, pathological cell categorisation, diag-nosis, reliable, effective, and targeted in vivo delivery, and additives that serve as microscopic models of the human body's damaged tissues and organs.
Design, classification, and adverse effects of NSAIDs: A review on recent advancements Minhajul Arfeen, Ashish Srivastava, Noopur Srivastava, Riaz A. Khan, Suliman A. Almahmoud, Hamdoon A. Mohammed Bioorganic and Medicinal Chemistry, 2024 Inflammation is a hallmark of many diseases, including cancer, neurodegenerative diseases like Alzheimer's, type II diabetes, rheumatoid arthritis, and asthma. Nonsteroidal anti-inflammatory drugs (NSAIDs) have been a cornerstone in the management of various inflammatory, pain, and fever-related conditions. As a result, NSAIDs have found their applications in new therapeutic areas. NSAIDs are known to act by inhibiting the cyclooxygenase (COX) pathway. In recent years, new strategies have been proposed to counter inflammation and develop safer COX inhibitors. This review discusses the design of new COX inhibitors, the derivatization of conventional NSAIDs, and their biological applications. The review also presents an integrated classification of NSAIDs incorporating both traditional chemical-based and function-based approaches, including a brief overview of the NSAIDs of natural origins. Additionally, the review addresses adverse effects associated with different NSAIDs, including effects associated with cardiovascular, renal, and hepatic complications emphasizing the need for the development of new and safer COX inhibitors.
The Role of Nutraceutical Supplements in the Treatment of Irritable Bowel Syndrome: A Mini Review Ankita Wal, Ashish Srivastava, Neha Verma, Shiv Shanker Pandey, Sachin Tyagi Current Pediatric Reviews, 2024 Background: Irritable bowel syndrome (IBS) is a prolonged bowel illness that is general-ly stress-related and is characterized by a variety of gastrointestinal problems, the most prominent of which is chronic visceral abdominal discomfort. As a result, IBS typically impacts sufferers' standard of living, and it is typically associated with depression and anxiety symptoms. IBS medica-tion is based mostly on symptom alleviation. However, no effective medicines have been discov-ered too far. As a result, it is essential to discover novel anti-IBS medications. Objective: The purpose of this brief review is to describe the existing research on nutraceutical sup-plements in irritable bowel syndrome management, including probiotics, prebiotics, symbiotics, herbal products, and dietary fibers. Methods: This review covered the relevant papers from the previous twenty years that were availa-ble in different journals such as Science Direct, Elsevier, NCBI, and Web of Science that were re-lated to the role and function of Nutraceuticals in Irritable Bowel Syndrome. Results: Neutraceutical substances have a variety of modes of action, including restoring the healthy microbiome, improving the function of the gastrointestinal barrier, immunomodulatory, an-ti-inflammatory, and antinociceptive properties. According to the literature, these substances not on-ly can improve irritable bowel syndrome symptomatology but also have an excellent long-term safety profile. Conclusion: Irritable bowel syndrome is a prolonged bowel illness with a lot of gastrointestinal problems. The nutraceuticals treatment works as an anti-IBS intervention and enhances patient compliance with minimum side effects since patients take it better than pharmaceutical treatments.
Spectroscopic and electrochemical investigation of mixed – ligand transition metal complexes with 2N-salicylidine-5-(p-nitrophenyl)-1, 3, 4-thiadiazole and 5, 5’-Me2bipy in aqueous medium Ashish Kumar Srivastava, Archana Rai Research Journal of Chemistry and Environment, 2023 Herein we reported the spectroscopic and electrochemical investigation of four transition metal complexes viz. VO(II), Co(II), Ni(II) and Cu(II) of 2N-salicylidine-5-(p-nitrophenyl)-1, 3, 4-thiadiazole Schiff base ligand (L) and 5,5’-dimethyl-2,2’-bipyridine (Me2bipy) in the aqueous (1: 1: 1 molar ratio) medium. Transition metal complexes were characterized by microanalysis, FT-IR, electronic absorption and mass spectroscopy. Electrochemistry of transition metal complexes was studied in aqueous medium by using cyclic voltammetry (CV) at glassy carbon working electrode (GCE) versus Ag/AgCl. The reduction potential of the VO (II) and Cu (II) becomes more negative with increasing scan rate while Co (II) and Ni (II) positive show easier reduction.
An overview of macrolactone in polymer synthesis Tiwari, Srivastava, Mishra Bulgarian Chemical Communications, 2023 The article uniquely describes the ring-opening polymerization (ROP) of macrolactones.Nature is the source of information, naturally occurring macrolides could assist in monomers design and synthesis.The available approaches in the synthesis of medium-sized amphidinolides Qalong with their retrosynthetic analysis are presented.The analogues of naturally occurring biologically relevant macrolactone could be the ideal monomers for chiral polyesters for various applications.
Synthesis, characterization and fluorescence properties of mixed-ligand cobalt(II), copper(II), zinc(II) and cadmium(II) coordination polymer complexes involving 4,4'-bipyridine and 2,5-pyridinedicarboxylic acid Research Journal of Chemistry and Environment, 2021
Formulation development, characterization & estimation of acid neutralization capacity of Shankha Bhasma tablets for the treatment of dyspepsia International Journal of Pharmacy and Pharmaceutical Sciences, 2014
Synthesis of novel 2-benzylbenzo[d] thiazole-6-sulfonamide derivatives as potential anti inflammatory agent Journal of Chemical and Pharmaceutical Sciences, 2014
DNA cleavage activity and cytotoxicity of mononuclear and trinuclear Cu(II) complexes containing 1H-pyrazole-3,5-dicarboxylic acid as ligand Indian Journal of Chemistry Section A Inorganic Physical Theoretical and Analytical Chemistry, 2013
Effect of nitrate seed priming on phenology, growth rate and yield attributes in rice (Oryza sativa L.) Vegetos, 2012
Impact of seed hardening treatment with nitrate salts on nitrogen and anti oxidant defense metabolisms in Triticum aestivum L. under different sowing conditions Vegetos, 2012
Electrochemistry and spectral studies of dinuclear dihydroxo-bridged copper(II) complexes Journal of the Indian Chemical Society, 2012
The Different Kinds of Reaction involved in synthesis of 2-substituted Benzothiazole and its derivatives: A review Research Journal of Pharmaceutical Biological and Chemical Sciences, 2012
Synthesis, characterization and electrochemical studies of mixed-ligand copper(II) complexes of 6-chloronicotinic acid and diimines Journal of the Indian Chemical Society, 2012
Electrochemical and spectral studies of binuclear monohydroxo-bridged copper(II) complexes Journal of the Indian Chemical Society, 2009
Cyclic voltammetric and spectral studies of some mixed-ligand copper(II) complexes involving 2,2′-bipyridine/1,10-phenanthroline and amino acids Journal of the Indian Chemical Society, 2009
Determination of dissociation constants of salicylic acids and stability constants of complexes of these ligands with copper(II), berylium(II) and iron(III) ions: Correlation of dissociation and stability constants with molecular descriptors Journal of the Indian Chemical Society, 2008
Effect of solvents on the electrochemical behaviour of copper(II,III) complexes with morpholinedithiocarbamato ligand Journal of the Indian Chemical Society, 2007
Preliminary analysis of cuprome of Anabaena doliolum using two-dimensional gel electrophoresis Current Science, 2006
Molecular insights into glial neuroimmune cross reactivity with CNS antigens and its role in neuroinflammation AK Yadav, P Verma, A Srivastava, P Srivastava, R Rai, S Rathour Inflammopharmacology, 1-26 , 2026 2026 Citations: 2
Aryloxyethylamines Chalcones as Potential β3 AR Binders: Synthesis, In Vivo Antidiabetic and Molecular Modeling Studies A Srivastava, L Kumar, P Srivastava, P Shukla, M Arfeen ChemistrySelect 11 (5), e05304 , 2026 2026
Modular Approach to In Silico Antiviral Multitargets Inhibitor: Molecular Dockings, Dynamics, Principal Component Analysis, Clustering, and Energy Landscape SA Almahmoud, HA Mohammed, M Arfeen, MM Hegazy, DK Dhaked, ... ChemistrySelect 11 (8), e05129 , 2026 2026 Citations: 1
Mucosal Vaccination in Pediatric Medicine A Srivastava, S Singh, DS Tomar, S Sharma, A Sharma Mucosal Vaccine Delivery Systems: The Future of Immunization (Part 1), 206-240 , 2025 2025
Exploring Microspheres: Innovative Approaches in Drug Delivery and Medication Administration P Srivastava, J Kaur, A Srivastava, A Wal, AK Yadav, P Wal, AK Rai Current Drug Therapy , 2025 2025
“Exploring the Potential of Benincasa hispida Sterols and Terpenes as Acetylcholinesterase Inhibitors for Alzheimer's Disease Therapy" PBAS Parul Srivastava1, Sonal H Vaishnav2, Dr. Annapragada Pratyusha3, Nidhi ... African Journal of Biological Sciences (South Africa) 6 (14), 9422 of 11 , 2024 2024
Hydroalcoholic Extract of Terminalia pallida Brandis for its Gastroprotective Effects in Wistar rats AKY 1Priyanka Verma, 1Ashish Srivastava, 1Parul Srivastava, 1Shashi P. Singh ... African journal of biological sciences 6 (14), 1738 to 10 , 2024 2024
Design, classification, and adverse effects of NSAIDs: A review on recent advancements MAASASNSS all 6 authorsHamdoon A. Mohammed Bioorganic & Medicinal Chemistry 112, 1-16 , 2024 2024 Citations: 91
"Exploring Benincasa hispida Constituents as Inhibitors of Monoamine Oxidase B: Insights from Molecular Docking" AS Parul Srivastava, Anil Kumar Yadav, Priyanka Verma, Ramji Mishra ... African Journal of Biological Sciences 6 (12), 5397 of 10 , 2024 2024
NOVEL CHALCONE DERIVATIVES AS POTENTIAL ANTIHYPERGLYCEMIC AGENTS: SYNTHESIS AND BIOLOGICAL EVALUATION PS Sudha Kumari, Ashish Srivastava African Journal of Biological Sciences (South Africa) 6 (12), 4613-4624 , 2024 2024
A COMPREHENSIVE ASSESSMENT ON CONVENTIONAL MEDICATIONS AND NUTRITIONAL SUPPLEMENTS AVAILABLE FOR HYPERLIPIDEMIA AS Aishwarya Bajpai, Ashish Srivastava, Anil K. Yadav African Journal of Biological Sciences 6 (11), 1043-1061 , 2024 2024
Evaluation of Antiviral, Antibacterial and Antioxidant Activity of Morinda tinctoria Roxb., Abroma augusta L. Educes and Myristica fragrans Houtt. Ethereal Oil in Microcapsules AKY Garima Verma1, Priyanka Verma2, Ashish Srivastava2 INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE 15 (2), 689-697 , 2024 2024
PREDICTIVE INSIGHTS INTO THE ADME AND TOXICOLOGICAL PROFILES OF ALLIUM SATIVUM PHYTOCHEMICALS USING SWISS ADME AND PROTOX-I PDNGRR Manukonda Upender Kumar, Dr Ashish Srivastava , Dr. Anandkumar K ... African Journal of Biological Sciences 6 (Issue - 6), 488-509 , 2024 2024
Liposomes as Transformative Tools in Drug Delivery, Therapeutics, and Beyond AKYAKR Ashish Srivastava*, Anshuman Singh, Parul Srivastava, Ankita Wal ... Current Drug Therapy , 2024 2024 Citations: 3
The Role of Nutraceutical Supplements in the Treatment of Irritable Bowel Syndrome: A Mini Review A Wal, A Srivastava, N Verma, SS Pandey, S Tyagi Current Pediatric Reviews 20 (1), 66-75 , 2024 2024 Citations: 3
Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management P Wal, H Vig, A Wal, S Rathore, SS Pandey, NK Jain, A Srivastava Current Aging Science 16 (3), 170-187 , 2023 2023 Citations: 8
Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments A Wal, P Wal, H Vig, NK Jain, S Rathore, K Krishnan, A Srivastava Current Drug Discovery Technologies 20 (5), 54-70 , 2023 2023 Citations: 11
A review on Phytosomes, their characterization method, advancement & potential application AY Ashish Srivastava* , Pranay Wal Versha Chaturvedi , Parul Srivastava ... YMER 22 (2), 141-187 , 2023 2023
A Comprehensive Review on Phytoconstituents and Pharmacological Activity of Holy Basil Ocimumsanctum (Tuls NKSS Anil K. Yadav* , Yash K. Singh, Pranay Wal, Ashish Srivastava, Ankita ... European Chemical Bulletin 12 (10), 2242-2275 , 2023 2023
Investigating the Drug Potential of a Natural COX Inhibitor: ADME and In Silico Analysis PS Ashish Srivastava, Ashutosh Verma ,Ankita Wal, Versha Chaturvedi, Pranay Wal Journal of Population Therapeutics and Clinical Pharmacology 29 (4), 1326–1342 , 2022 2022
MOST CITED SCHOLAR PUBLICATIONS
Design, classification, and adverse effects of NSAIDs: A review on recent advancements MAASASNSS all 6 authorsHamdoon A. Mohammed Bioorganic & Medicinal Chemistry 112, 1-16 , 2024 2024 Citations: 91
Therapeutic potential of prodrugs towards targeted drug delivery AP Mishra, S Chandra, R Tiwari, A Srivastava, G Tiwari The open medicinal chemistry journal 12, 111 , 2018 2018 Citations: 47
SYNTHESIS OF NOVEL 2-BENZYLBENZO[d] THIAZOLE-6-SULFONAMIDE DERIVATIVES AS POTENTIAL ANTI INFLAMMATORY AGENT REENA MAHTAB1 , ASHISH SRIVASTAVA1 , NISHI GUPTA1 , SANDEEP KUMAR KUSHWAHA2 ... Journal of Chemical and Pharmaceutical Sciences 7 (Issue 1), 34-38 , 2014 2014 Citations: 26
Phytochemical profiling, molecular docking, and in vitro anti-hepatocellular carcinoid bioactivity of Suaeda vermiculata extracts * Hamdoon A. Mohammed a,b, *, Sulaiman A. Almahmoud a , Minhajul Arfeen a ... Arabian Journal of Chemistry 15, 1-13 , 2022 2022 Citations: 23
The Different Kinds of Reaction involved in synthesis of 2-substituted Benzothiazole and its derivatives: A Review S Jaiswal, AP Mishra, A Srivastava Res. J. Pharm. Biol. Chem. Sci 3, 631-641 , 2012 2012 Citations: 18
Benzothiazole derivative: A review on its pharmacological importance towards synthesis of lead A Srivastava, AP Mishra, S Chandra, A Bajpai Int. J. Pharm. Sci. Res 10 (4), 1553-66 , 2019 2019 Citations: 17
Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments A Wal, P Wal, H Vig, NK Jain, S Rathore, K Krishnan, A Srivastava Current Drug Discovery Technologies 20 (5), 54-70 , 2023 2023 Citations: 11
Nsaids-alendronate based prodrug for bone specific drug targeting A Srivastava, A Mishra, AK Rai Research Journal of Pharmacy and Technology 13 (7), 3520-3523 , 2020 2020 Citations: 10
Synthesis, Characterization and Evaluation of Ulcerogenic potential for NSAIDs-Alendronate based prodrug A Srivastava, A Mishra, AK Rai Research journal of pharmacy and technology 13 (5), 2107-2111 , 2020 2020 Citations: 9
Formulation development, characterization & estimation of acid neutralization capacity of Shankha Bhasma tablets for the treatment of dyspepsia A Seth, SK Maurya, A Srivastava Int J Pharm Pharm Sci 6 (2), 467-9 , 2014 2014 Citations: 9
Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management P Wal, H Vig, A Wal, S Rathore, SS Pandey, NK Jain, A Srivastava Current Aging Science 16 (3), 170-187 , 2023 2023 Citations: 8
Physico-chemical and phytochemical evaluation of crude drug powder (leaves) of Polyalthia longifolia RS Pal, Y Pal, AK Rai, P Wal, A Wal, A Srivastava, S Chandra, ... Journal of pharmacognosy and phytochemistry 5 (3), 212-213 , 2016 2016 Citations: 7
SUSTAINABILITY IN PHARMACEUTICALS: AN IN-DEPTH LOOK AT THE GREEN PHARMACY PRINCIPLES PS Parul Srivastava1*, Ankita Wal2,Versha Chaturvedi3,Pranay Wal4 ... Journal of Population Therapeutics and Clinical Pharmacology 29 (4), 1304–1325 , 2022 2022 Citations: 4
Liposomes as Transformative Tools in Drug Delivery, Therapeutics, and Beyond AKYAKR Ashish Srivastava*, Anshuman Singh, Parul Srivastava, Ankita Wal ... Current Drug Therapy , 2024 2024 Citations: 3
The Role of Nutraceutical Supplements in the Treatment of Irritable Bowel Syndrome: A Mini Review A Wal, A Srivastava, N Verma, SS Pandey, S Tyagi Current Pediatric Reviews 20 (1), 66-75 , 2024 2024 Citations: 3
A Comprehensive Review on Monkeypox Virus Transmission, Pathogenesis, Treatments and its Preventive Measures ZN Anil K. Yadav , Ashish Srivastava , Priyanka Verma , Parul Srivastava ... NeuroQuantology 20 (10), 7320-7335 , 2022 2022 Citations: 3
A Comprehensive Review on the Medicinal Plants for the Treatment of Headache. A WAL, P WAL, S SHUKLA, A SRIVASTAVA International Journal of Pharmaceutical Research (09752366) 13 (3) , 2021 2021 Citations: 3
Role of epigenetic mechanisms in various cancer therapies R Yadav, A Srivastava, S Chandra, AK Rai Pharmaceutical and Biological Evaluations 3 (2), 178-184 , 2016 2016 Citations: 3
Molecular insights into glial neuroimmune cross reactivity with CNS antigens and its role in neuroinflammation AK Yadav, P Verma, A Srivastava, P Srivastava, R Rai, S Rathour Inflammopharmacology, 1-26 , 2026 2026 Citations: 2
The Structure and Mechanism of Spike Protein, as Well as its Role in Numerous Viral Diseases. P Wal, A Wal, H Vig, A Srivastava, A Kumar International Journal of Pharmaceutical Investigation 12 (2) , 2022 2022 Citations: 2
